GMAB Competitors & Alternatives
Compare Genmab AS with similar stocks in the same industry
Biotechnology
GMAB
Main Stock$28.59
Tradestie Score
59
Market Cap
$19.56B
P/E Ratio
22.1
Revenue Growth
0.3%
Analyst Upside
+28.5%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BNTX
BioNTech SE American Depositary Share
|
$89.52
|
$24.57B | - | 55 | Compare |
|
INCY
Incyte Genomics Inc
|
$113.58
|
$16.93B | 16.5 | 57 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$55.94
|
$15.70B | 29.7 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.32
|
$15.22B | - | 53 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$267.71
|
$12.36B | 31.3 | 61 | Compare |
|
EXEL
Exelixis Inc
|
$55.55
|
$11.09B | 18.7 | 68 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$34.84
|
$10.76B | - | 67 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$66.58
|
$10.74B | - | 57 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.52
|
$10.53B | 42.5 | 66 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$55.58
|
$10.49B | - | 44 | Compare |
More GMAB Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry